ArticleFrontiers in molecular biosciences2021

The Specific NLRP3 Antagonist IFM-514 Decreases Fibrosis and Inflammation in Experimental Murine Non-Alcoholic Steatohepatitis.

Sandra Torres et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.